Advancing Access to Diagnostic Tools Essential for Universal Health Coverage and Antimicrobial Resistance Prevention: An Overview of Trials in Sub-Saharan Africa

Clin Infect Dis. 2023 Jul 25;77(Suppl 2):S125-S133. doi: 10.1093/cid/ciad326.

Abstract

We introduce the Antimicrobial Resistance Diagnostic Use Accelerator program, and the articles in this Supplement, which cover the program in 3 sub-Saharan Africa countries.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Africa South of the Sahara
  • Anti-Bacterial Agents* / therapeutic use
  • Drug Resistance, Bacterial
  • Health Services Accessibility
  • Humans
  • Universal Health Insurance*

Substances

  • Anti-Bacterial Agents